The United States Atherectomy Devices Market is expected to expand from US$ 316.05 Million in 2024 to US$ 627.59 Million by 2033. The growth signifies an impressive Compound Annual Growth Rate (CAGR) of 7.92% during the period 2025-2033. Drivers for this growth are a rising incidence of cardiovascular disorders, medical technology advancements, and a surge in demand for minimal invasive treatments, improving patient outcomes and fueling market expansion.
There are a number of different atherectomy devices, such as directional, rotational, and laser atherectomy. They all use a different process to attack and ablate the plaque. For example, laser atherectomy has focused light energy that causes the plaque to vaporize, whereas rotational atherectomy utilizes a rotating burr at high speed to mechanically grind through the blockage.
Atherectomy devices are commonly combined with angioplasty and stenting to improve the success of these interventions. They are essential in treating conditions such as coronary artery disease and peripheral arterial disease, serving to relieve symptoms, enhance quality of life, and minimize the risk of severe cardiovascular events.
2. Abbott Laboratories
3. Medtronic plc
4. Cardinal Health
5. Terumo Corporation
6. Integer Holdings Corporation
7. Becton, Dickinson and Company
8. AngioDynamics Inc.
United States Atherectomy Devices Market Outlook
Atherectomy devices are designed medical devices used in the management of atherosclerosis, a disease where there is an accumulation of plaque in the arteries. Atherectomy devices are meant to ablate or excise the plaque to enhance the flow of blood, especially in the case of patients with cardiovascular disease. In the USA, atherectomy is frequently employed during percutaneous coronary interventions (PCI) and peripheral artery interventions (PAI).There are a number of different atherectomy devices, such as directional, rotational, and laser atherectomy. They all use a different process to attack and ablate the plaque. For example, laser atherectomy has focused light energy that causes the plaque to vaporize, whereas rotational atherectomy utilizes a rotating burr at high speed to mechanically grind through the blockage.
Atherectomy devices are commonly combined with angioplasty and stenting to improve the success of these interventions. They are essential in treating conditions such as coronary artery disease and peripheral arterial disease, serving to relieve symptoms, enhance quality of life, and minimize the risk of severe cardiovascular events.
Growth Drivers in United States Atherectomy Devices Market
Increasing Incidence of Peripheral Artery Disease (PAD) and Cardiovascular Conditions
Peripheral artery disease (PAD) affects >12 million Americans and 200 million people globally. PAD is differentially prevalent and clinically impactful in demographic subgroups in the United States. The United States is experiencing a rapidly expanding burden of peripheral artery disease (PAD), atherosclerosis, and other cardiovascular conditions fueled by aging, physical inactivity, obesity, and diabetes. Millions of Americans have PAD, much of it undiagnosed until late in the disease, says the CDC. Atherectomy devices, which aim to clear plaque from arteries and restore blood flow, are increasingly important for treating severe cases. Drivers include the demand for less invasive procedures with shorter hospital stays and recovery times. As patients increase, so does the need for sophisticated atherectomy technology that will treat large volumes of patients effectively, hospitals and physicians agree.Technological Developments in Atherectomy Devices
Ongoing development of atherectomy technologies is fueling uptake in U.S. hospitals and specialty clinics.Devices are now enhanced with better plaque removal efficacy, integration of real-time imaging, and reduced complications. New technologies such as laser and orbital atherectomy systems are improving procedural safety, precision, and patient outcomes. Furthermore, the creation of portable and simple-to-use systems is opening up access in outpatients. The U.S. market also enjoys significant investment in R&D by medical device titans, promoting competitive product introductions. These technologies are enhancing the effectiveness of atherectomy procedures, further increasing physician confidence and patient demand for minimally invasive cardiovascular procedures. Nov 2024, Royal Philips announced enrollment of the first patient in the U.S. THOR IDE trial, which will evaluate its new combined laser atherectomy and intravascular lithotripsy catheter for the treatment of PAD.Reimbursement and Healthcare Coverage Expansion
The U.S. healthcare system continues to acknowledge atherectomy as an important treatment method for PAD and coronary artery disease, which results in enhanced reimbursement policies. Private payers and Medicare continue to expand coverage for atherectomy procedures, eliminating financial obstacles for patients. Positive reimbursement incentivizes clinics and hospitals to embrace advanced devices, confident that expenses are compensated by insurance. This has been particularly significant for older patients, who are most impacted by PAD and rely substantially on Medicare. As reimbursement models become more favorable, use of atherectomy devices further speeds up, building market growth and enhancing access to high-tech cardiovascular treatments.Challenges in the United States Atherectomy Devices Market
High Device and Procedure Cost
One of the major challenges for the U.S. atherectomy market is the high expense of devices and procedures. High-end atherectomy systems can be costly for clinics and hospitals, necessitating heavy capital equipment and consumable expenditures. Even with insurance, out-of-pocket costs can be high for patients, deterring use. Moreover, cost containment pressures on healthcare providers commonly restrict widespread usage. Less expensive facilities, especially, have affordability issues, creating unequal access throughout the nation. Without additional cost savings or increased reimbursement, the market stands to experience slower penetration in spite of robust clinical demand for minimally invasive treatment.Procedural Risks and Limited Skilled Professionals
In spite of technology advancements, atherectomy procedures inherently involve risks, such as arterial perforation, distal embolization, and restenosis. Complications require highly trained operators with long-term training. Nonetheless, a lack of trained interventional cardiologists and vascular surgeons skilled in complex atherectomy technologies exists, particularly for rural and underserved areas. Education programs can take time and money, limiting the rate of workforce growth. In addition, patient safety issues might inhibit physician acceptance of particular device styles. Mitigating procedural risks by innovation, along with increasing specialized training, continues to be crucial in addressing this obstacle and fueling wider adoption in the U.S. market.United States Directional Atherectomy Devices Market
The directional atherectomy device segment is picking up pace in the U.S. as it can selectively ablate targeted plaque without affecting healthy arterial tissue. The preference of physicians for this type of device lies in its precision and efficacy in curing complex, calcified, or eccentric lesions. The enhancement of catheter design and real-time imaging integration has further enhanced clinical results. Increasing adoption is bolstered by favorable reimbursement and extensive use in treatment of peripheral artery disease. Hospitals and specialty cardiovascular clinics in the U.S. increasingly depend on directional atherectomy for minimally invasive procedures, positioning this as a key driver of market growth.United States Laser Atherectomy Devices Market
Laser atherectomy products are a fast-growing category in the United States based on their capacity to vaporize plaque with ultraviolet light, minimizing the risk of mechanical injury to arterial walls. The products find special application in treating in-stent restenosis and complex lesions. Advances in technology have increased safety, user convenience, and effectiveness, driving physician adoption. Hospitals and ambulatory surgical centers are increasingly using laser atherectomy in PAD and coronary artery disease treatments. Reimbursement support and robust demand for minimally invasive therapy drive growth. With continued advancements, laser atherectomy devices will capture a more significant portion of the U.S. market.United States Cardiovascular Atherectomy Devices Market
Cardiovascular atherectomy in the U.S. is growing as cardiovascular diseases are the largest cause of death. Atherectomy devices to eliminate arterial plaque offer a critical intervention for high-risk patients such as those with coronary artery disease. Doctors are increasingly resorting to atherectomy alongside stenting or balloon angioplasty to enhance long-term results. Development is enabled by an aging population, extensive health screening, and a developed infrastructure for healthcare. Clinical evidence continues to support the effectiveness of atherectomy in high-risk individuals, enhancing confidence among healthcare providers. This category is anticipated to stay at the forefront of the overall atherectomy devices market growth.United States Atherectomy Devices Hospital Market
U.S. hospitals are responsible for the majority of atherectomy procedures because they have more developed infrastructure, access to specialized interventional cardiologists, and capability to manage complicated cases. Hospitals tend to purchase more than one device platform, giving physicians freedom to select the most suitable instrument per patient. In addition, hospitals enjoy reimbursement systems and collaborations with insurance companies, guaranteeing financial viability. Most hospitals also engage in clinical research, enhancing innovation and market expansion. Due to the rising need for minimally invasive cardiovascular procedures, hospitals are the cornerstone of the U.S. atherectomy devices market, propelling volume as well as technological use.United States Atherectomy Devices Market
The U.S. atherectomy devices market is one of the most sophisticated in the world due to a high prevalence of cardiovascular diseases, technological advancement, and robust reimbursement policies. Patients enjoy a broad array of device choices, such as directional, orbital, rotational, and laser atherectomy systems. Major medical device firms keep introducing new products and widening indications, boosting clinical uptake. Though high expenses and procedural risk are issues, robust healthcare infrastructure and a vast pool of experienced professionals underpin growth. High demand for minimally invasive technology guarantees growth in the U.S. market, with it being a key player in worldwide atherectomy development.California Atherectomy Devices Market
California is one of the biggest state-level markets for atherectomy devices in the U.S., backed by its extensive healthcare network, top research facilities, and high incidence of cardiovascular disease. There are various medical device pioneers and hospitals in the state that lead the adoption of innovative cardiovascular technologies. Increasing patient awareness, combined with supportive insurance environments, is driving demand. Medical tourism is also a contributing factor, with patients going to California for specialized treatment. The state's aging demographic and high prevalence of diabetes also help to fuel the market. California remains a key growth center for atherectomy devices.New York Atherectomy Devices Market
New York is a primary state market, defined by sophisticated hospital systems, specialty cardiovascular hospitals, and strong demand for new medical devices. High population density and high incidence rates of diabetes and peripheral artery disease propel demand for atherectomy procedures. Major New York City hospitals tend to act as referral centers for complicated cases, fueling adoption of innovative atherectomy technologies. Favorable reimbursement plans and robust physician experience enable long-term growth. The state also has an active research base in the medical community with contributions to clinical trials and innovation. As demand for minimally invasive cardiovascular procedures increases, New York continues to be a solid market.New Jersey Atherectomy Devices Market
New Jersey's market for atherectomy devices is increasing steadily, spurred by its aging population and high incidence of lifestyle-related cardiovascular illness. New Jersey's proximity to key medical centers like New York and Philadelphia provides access to cutting-edge cardiovascular care. New Jersey specialty clinics and hospitals are increasingly using atherectomy devices to treat complicated peripheral artery disease and coronary conditions. Expansion of insurance coverage and access to knowledgeable specialists also promote adoption. As small as the market may be in relation to California or New York, New Jersey is an expanding regional market that is full of promise, especially in cardiovascular care offered within hospitals and outpatient settings.Market Segmentations
Product Type
- Directional
- Rotational
- Orbital
- Laser
Application
- Cardiovascular
- Neurovascular
- Peripheral Vascular
End User
- Hospitals
- Ambulatory Care Service
- Medical Research Institutes
Top States
- California
- Texas
- New York
- Florida
- Illinois
- Pennsylvania
- Ohio
- Georgia
- New Jersey
- Washington
- North Carolina
- Massachusetts
- Virginia
- Michigan
- Maryland
- Colorado
- Tennessee
- Indiana
- Arizona
- Minnesota
- Wisconsin
- Missouri
- Connecticut
- South Carolina
- Oregon
- Louisiana
- Alabama
- Kentucky
- Rest of United States
All companies have been covered with 5 Viewpoints
- Overviews
- Key Person
- Recent Developments
- SWOT Analysis
- Revenue Analysis
Key Players Analysis
1. Boston Scientific Corporation, Inc.2. Abbott Laboratories
3. Medtronic plc
4. Cardinal Health
5. Terumo Corporation
6. Integer Holdings Corporation
7. Becton, Dickinson and Company
8. AngioDynamics Inc.
Table of Contents
1. Introduction3. Executive Summary11. Value Chain Analysis
2. Research & Methodology
4. Market Dynamics
5. United States Atherectomy Devices Market
6. Market Share Analysis
7. Product Type
8. Application
9. End User
10. Top States
12. Porter's Five Forces Analysis
13. SWOT Analysis
14. Pricing Benchmark Analysis
15. Key Players Analysis
Companies Mentioned
- Boston Scientific Corporation, Inc.
- Abbott Laboratories
- Medtronic plc
- Cardinal Health
- Terumo Corporation
- Integer Holdings Corporation
- Becton, Dickinson and Company
- AngioDynamics Inc.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | August 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 316.05 Million |
| Forecasted Market Value ( USD | $ 627.59 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | United States |
| No. of Companies Mentioned | 8 |
